DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20172304

Effect of hormonal and copper IUDs on genital microbial colonisation and clinical outcomes in North-Western Nigeria

Abdulhadi D. Saidu, Karima A. Tunau, Abubakar A. Panti, Emmanuel I. Nwobodo, Yahaya Mohammed, Jamila Amin, Jamila A. Garba

Abstract


Background: Intrauterine devices are one of the popular long term reversible contraceptive methods. Earlier forms were associated with genital infections, however more recent types such copper IUDs and hormonal types have been shown to have better safety profile. However, there is no conclusive evidence to demonstrate that hormonal IUD is less associated with genital infection when compared with copper IUDs. The objectives include determination of prevalence of genital tract infections among IUD users, to determine the type of IUD that is less associated with genital infection, and also determine clinical features seen among IUD users.

Methods: We conducted a descriptive, cross sectional study of clients who were at 6 months following IUD insertion. Endocervical and high vaginal samples were taken to isolate microbes.

Results: The prevalence of genital tract infection was 20% in Copper IUD users and 8.6% among LNG-IUS users. Genital infection was significantly higher among copper IUD users compared to hormonal IUD users (p=0.038, OR= 2.88). Abnormal vaginal discharge was the commonest symptoms among IUD users and formal education was associated with less risk of genital infections (p=0.048).

Conclusions: Hormonal IUDs are less associated with genital tract infection compared to copper IUDs and women with formal education are less likely to have genital infection among IUD users.


Keywords


Copper IUD, Genital infection, LNG-IUS

Full Text:

PDF

References


Tietze C, Lewit S. Intrauterine contraceptives devices. Amsterdam: Excerpta Medica International Congress Series; 1962:54.

Hubacher D. Intrauterine device and infection: Review of the literature. Indian J Med Res. 2014;140:53-7.

Farley TM, Rosenborg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine device and pelvic inflammatory disease. Lancet. 1992;339:785-8.

Egbe CA, Onwufor UC, Omoregie R, Enabulele OI. Female reproductive tract infections among vaginal contraceptive users in Benin City, Nigeria. Genomic Medicine Biomarkers, and Health Sciences. 2011:3(2):49-52.

Alawad A, Bashir ME. Association of infection among intrauterine contraceptive device users in family planning clinics in Sudan. Int J Health. 2014;2(2):50-60.

Musmar SG, Musmar M, Isma MA. Effect of IUD (intrauterine device) on reproductive tract infection (RTI) in the northern Westbank. Middle East Journal of Family Medicine (Online) 2004;5(5). Available from: http://mejfm.com./journal/MEJFM%20May%202014/IUD1.htm. Accessed on 03/12/2015

Poonam PS, Naveen CK. Intruterine devices and reproductive tract infections: a cross-sectional study in urban slum. National J Comm Med. 2015;6(4):575-8.

Ruyer D, Mehmet D, Hamdi S, Yaprak E, Eren A, Halil B. Infection frequency among intrauterine copper T-380A contraceptive users, Acter Medica Mediterranea. 2013;29:489-92.

Patel SV, Baxi RK, Kotecha PV. A case control study of pelvic inflammatory disease and its association with IUD. J Obstet Gynecol India. 2008,54(4):333-7.

Kabir AK, Jaynul I, Shirin A. A study on prevalence of reproductive tract infections amongst women attending in an urban clinic. Chattagram Maa-O-Shishu Hospital Medical College Journal. 2014;13(1):32-5.

Ocak S, Cetin M, Hakverdi S, Dolapcioglu K, Gungoren A, Hakverdi A. Effects of intrauterine device and oral contraceptive on vaginal flora and epithelium. Saudi Med J. 2007;28(5):727-31.

Shobeiri F, Nazari M. Vaginitis in intrauterine contraceptive device users. Health. 2014;6(11). Available from: http://creative commons.org/licences/by/4.0[accessed February, 2016].

Agarwal K, Sharma U, Acharya V. Micrbiological and cytopathological study of intrauterine contraceptive device users. Indian J Med Sci. 2004;58(9):394-9.

Serap S, Aysel D, Aylin A, Hassan K. The impact copper-containing and levonorgestrel-releasing intrauterine contraceptives on cervicovaginal cytology and microbiological flora: A prospective study. European J Contracep Reprod Health Care. 2014;19(3):187-93.

Toivonen J, Luukkainen T, Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: Three years’ comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynaecol. 1991;77(2):261-4.

Anderson K, Odlind V, Rybo G. Levonorgestrel releasing and copper releasing (Nova T) IUDs during 5years of use: a randomised comparative trial. Contraception. 1994;49:56-72.

Sivin I, Stern J, Coutinho E, Mattos CE, Mahgoub S, Diaz S. Prolonged intrauterine contraception: A seven year randomised study of the levonorgestrel 20mcg/day and copper T380A IUD. Contraception. 1991;44:473-840.

Sharief M. Genital infections among women using various contraceptive methods in Basra, Iraq. Eastern Mediterranean Health Journal. 1998;4(3):487-92.